Kyung Hyun Yoo
Overview
Explore the profile of Kyung Hyun Yoo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
1000
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim J, Jeong G, Yoo Y, Bhang S, Kim J, Shin Y, et al.
Biofabrication
. 2025 Mar;
PMID: 40081017
In vitro modeling of vascular diseases provides a useful platform for drug screening and mechanistic studies, by recapitulating the essential structures and physiological characteristics of the native tissue. Bioprinting is...
2.
Jun J, Cha H, Ko J, Kim H, Yoo K, Park J
Sci Rep
. 2025 Jan;
15(1):2127.
PMID: 39820844
Primary cilia are sensory organelles that regulate various signaling pathways. When microtubules are compared to a highway, motor proteins carry and transport cargo proteins, which are tuned by post-translational modifications,...
3.
Han S, Ko J, Jung S, Oh S, Kim D, Kang E, et al.
Exp Mol Med
. 2024 Dec;
56(12):2617-2630.
PMID: 39617786
Early tumor recurrence in hepatocellular carcinoma (HCC) remains a challenging area, as the mechanisms involved are not fully understood. While microvascular invasion is linked to early recurrence, established biomarkers for...
4.
Bang H, Shim H, Park M, Yoon S, Yoo K, Kim Y, et al.
Int J Mol Sci
. 2024 Nov;
25(21).
PMID: 39518976
The role of biomarkers in cancer treatment varies significantly depending on the cancer stage. Thus, in clinical practice, tailoring biomarkers to meet the specific needs and challenges of each cancer...
5.
Kim D, Sung M, Park M, Sun E, Yoon S, Yoo K, et al.
Cancer Commun (Lond)
. 2024 Jul;
44(10):1106-1129.
PMID: 39073023
Background: Increased Galectin 3-binding protein (LGALS3BP) serum levels have been used to assess hepatic fibrosis stages and the severity of hepatocellular carcinoma (HCC). Considering the crucial role of transforming growth...
6.
Kim Y, Ko J, Kong H, Lee M, Chung W, Lim S, et al.
Cancers (Basel)
. 2024 May;
16(9).
PMID: 38730618
Dysregulated DNA methylation in cancer is critical in the transcription machinery associated with cancer progression. Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype, but no treatment targeting...
7.
Jung S, Yoon S, Park J, Lee Y, Yoo K
Clin Mol Hepatol
. 2024 Feb;
30(2):287-290.
PMID: 38390704
No abstract available.
8.
Kim D, Shah M, Kim J, Kim J, Baek Y, Jeong J, et al.
Hepatology
. 2024 Feb;
81(3):962-975.
PMID: 38385945
Background And Aims: Metabolic dysfunction-associated steatotic liver disease (MASLD) encompasses a broad and continuous spectrum of liver diseases ranging from fatty liver to steatohepatitis. The intricate interactions of genetic, epigenetic,...
9.
Oh S, Baek Y, Jung S, Yoon S, Kang B, Han S, et al.
Clin Mol Hepatol
. 2024 Jan;
30(2):247-262.
PMID: 38281815
Background/aims: Metabolic dysfunction-associated steatotic liver disease (MASLD) is characterized by fat accumulation in the liver. MASLD encompasses both steatosis and MASH. Since MASH can lead to cirrhosis and liver cancer,...
10.
Park S, Lee J, Ahn K, Shim H, Yoon J, Hyun J, et al.
Adv Sci (Weinh)
. 2023 Sep;
10(32):e2303395.
PMID: 37727069
Advancing the technologies for cellular reprogramming with high efficiency has significant impact on regenerative therapy, disease modeling, and drug discovery. Biophysical cues can tune the cell fate, yet the precise...